Advancing T cell-based cancer therapy with single-cell technologies

Affiliations

• ¹ Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA. sbucktrout@parkerici.org.
• ² Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
• ³ Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.
• ⁴ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁵ Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.
• ⁶ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁷ Stanford Cancer Institute and Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
• ⁸ Microbiology and Immunology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.
• ⁹ Department of Applied Mathematics, University of California, Santa Cruz, Santa Cruz, CA, USA.
• ¹⁰ Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
• ¹¹ Genomics Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.
• ¹² Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
• ¹³ Gladstone-UCSF Institute for Genomic Immunology, San Francisco, CA, USA.
• ¹⁴ 10x Genomics, Pleasanton, CA, USA.